In the last 12 months, insiders at Nascent Biotech Inc. ($NBIO) filed 9 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Nascent Biotech Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Carrick Sean (President & CEO) — 3 transactions totaling $99,474
- HOLDEN LOWELL THOMAS (CFO) — 3 transactions totaling $49,737
- Karas Douglas John (Not found) — 3 transactions totaling $15,208
View all SEC Filings for Nascent Biotech Inc. (NBIO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2024 | Karas Douglas John | Not found | J | Common stock | 50000 | $0.10 | 1,821,552.0000 | 172,202,165 | 2.82% | 0.03% |
| June 30, 2024 | HOLDEN LOWELL THOMAS | CFO | J | Common stock | 96000 | $0.09 | 10,005,477.0000 | 172,202,165 | 0.97% | 0.06% |
| June 30, 2024 | Carrick Sean | President & CEO | J | Common stock | 192000 | $0.09 | 23,126,007.0000 | 172,202,165 | 0.84% | 0.11% |
| March 31, 2024 | HOLDEN LOWELL THOMAS | CFO | J | Common Stock | 112500 | $0.18 | 11,909,477.0000 | 0 | 0.95% | 0.00% |
| March 31, 2024 | Carrick Sean | President & CEO | J | Common Stock | 225000 | $0.18 | 22,934,007.0000 | 0 | 0.99% | 0.00% |
| March 31, 2024 | Karas Douglas John | Not found | J | Common Stock | 27100 | $0.18 | 1,771,552.0000 | 0 | 1.55% | 0.00% |
| Dec. 29, 2023 | Carrick Sean | President & CEO | J | Common Stock | 239300 | $0.17 | 22,709,007.0000 | 0 | 1.06% | 0.00% |
| Dec. 29, 2023 | HOLDEN LOWELL THOMAS | CFO | J | Common Stock | 119650 | $0.17 | 11,796,977.0000 | 0 | 1.02% | 0.00% |
| Dec. 29, 2023 | Karas Douglas John | Not found | J | Common Stock | 28935 | $0.18 | 1,744,452.0000 | 0 | 1.69% | 0.00% |